Library Home | Reset filters
Select one or more filter options and click search below.
Reset filters
AUTHOR(S) Dusan Bogunovic; Miriam Merad
AUTHOR(S) Stephen T. J. Ray; Omar Abdel-Mannan; Mario Sa (et al.)
AUTHOR(S) Omran A. H. Musa; Tawanda Chivese; Devendra Bansa (et al.)
AUTHOR(S) S. Bookstein Peretz; N. Regev; L. Novick (et al.)
This study aims to determine the immunogenicity and reactogenicity of Pfizer's BNT162b2 COVID-19 vaccine among pregnant women compared with non-pregnant women, and to evaluate the obstetric outcome following vaccination. An observational case-control study of pregnant women, who were vaccinated by a 2-dose regimen of BNT162b2 vaccine during gestation between January-February 2021 (study group) and were compared to age-matched non-pregnant women who received the vaccine during the same time period (control group).
AUTHOR(S) Benjamin Fogel; Eric W. Schaefer; Steven D. Hicks
This investigation sought to determine whether early season rates of pediatric influenza vaccination changed in a season when there was a concurrent COVID-19 pandemic. This study used cohort and cross sectional data from an academic primary care division in Southcentral Pennsylvania that serves approximately 17,500 patients across 4 practice sites. Early season (prior to November 1) vaccination rates in 2018, 2019 and 2020 were recorded for children, age 6 months to 17 years.
AUTHOR(S) Kenneth J. Smith; Angela R. Wateska; Mary Patricia Nowalk (et al.)
AUTHOR(S) C. Sarai Racey; Robine Donken; Imogen Porter (et al.)
AUTHOR(S) Kristine M. Ruggiero; John Wong; Casey Fryer Sweeney (et al.)
With the COVID-19 vaccine rollout is well underway now beginning in children ages 12 and over, it is unknown what percent of parents plan to vaccinate their children against COVID-19. The purpose of this descriptive correlational study was to examine parents’ attitudes, beliefs, and behaviors in administering a COVID-19 vaccine.
AUTHOR(S) Defne Saatci; Tom A. Ranger; Cesar Garriga (et al.)
Although children mainly experience mild COVID-19 disease, hospitalization rates are increasing, with limited understanding of underlying factors. There is an established association between race and severe COVID-19 outcomes in adults in England; however, whether a similar association exists in children is unclear. This article aims to investigate the association between race and childhood COVID-19 testing and hospital outcomes.
AUTHOR(S) Cirenia Chávez; Marco Valenza; Annika Rigole; Thomas Dreesen
The COVID-19 pandemic has disrupted every aspect of society. In mid-April 2020, 192 countries had closed their schools, putting 9 out of 10 enrolled children out of school.
These closures disproportionately affected marginalized children, worsening existing inequities across education systems worldwide.
This brief draws on the experience of five UNICEF education country programmes supported by the Let Us Learn (LUL) initiative, to document tangible lessons in adapting education programmes to support the most marginalized children during school and learning centre closures.
The evidence in this brief stems from a series of semi-structured interviews with Education and Child Protection specialists, as well as a document review of available COVID-19 response studies, in the five LUL-supported UNICEF Country Offices.
While there has been a global rush to generate rapid evidence on COVID-19 mental health impacts among adults, limited evidence exists on the potential impacts on children.
This is the protocol for our rapid review that seeks to (i) understand the immediate impact of COVID-19’s first wave on the mental health of children and adolescents (0–19 years); and (ii) apply lessons learned from this pandemic to mitigate the impacts of future health crises.
The key research questions of this review are:
AUTHOR(S) Lindsay A. Thompson; Sonja A. Rasmussen
Nearly 4 million children in the US have been infected with COVID-19 as of May 2021. While most children have had mild or no symptoms, thousands have been hospitalized and several hundred have died. Children with underlying conditions are more likely to experience severe effects of COVID-19, but even healthy children can be severely affected. Children can spread COVID-19 to others and also can have long-term effects that last months. For these reasons, children need to be protected from COVID-19. Currently, 3 vaccines are authorized for adults in the United States. In studies of tens of thousands of people, these vaccines were safe and effective. The vaccine made by Pfizer was recently authorized for children 12 years and older. Two doses of this vaccine are recommended to be given 3 weeks apart. The other 2 vaccines were authorized for persons 18 years and older but are expected to be available for teenagers soon. Studies in younger children as young as age 6 months are ongoing and if these studies show that they are safe and effective, vaccines could be available for children 6 months and older by late 2021 or early 2022.
AUTHOR(S) Gilbert G. G. Donders; Svitrigaile Grinceviciene; Kai Haldre (et al.)
AUTHOR(S) Simegnew Handebo; Maereg Wolde; Kegnie Shitu
Scientists across the world are working on innovating a successful vaccine that will save lives and end COVID-19 pandemic. World Health Organization (WHO) is working to make sure COVID-19 vaccines can be safely delivered to all those who need them. Indeed, the successful deployment and a sufficient uptake of vaccines is equally important. Acceptance and accessibility of such vaccine is a key indicator of vaccination coverage. This study aimed to assess the determinants of intention to receive COVID-19 vaccine among school teachers in Gondar City.
AUTHOR(S) Zixin Wang; Rui She; Xi Chen (et al.)
UNICEF Innocenti's Children and COVID-19 Library is a database collecting research from around the world on COVID-19 and its impacts on children and adolescents.
Subscribe to updates on new research about COVID-19 & children
Check our quarterly thematic digests on children and COVID-19
COVID-19 & Children: Rapid Research Response